CD20-positive B-cell Non-Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch CD20-positive B-cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. (NCT05395533) | Zhejiang Teruisi Pharmaceutical Inc. | 2020-09-08 |
| A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas (NCT04103905) | Beijing Mabworks Biotech Co., Ltd. | 2017-02-10 |
| A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma (NCT01569750) | Janssen Research & Development, LLC | 2012-06-14 |
Track CD20-positive B-cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.